Journal of Rheumatic Diseases

Table. 2.

Comparison between Fibromyalgia patients with and without tinnitus

Variable Fibromyalgia with tinnitus (n=22) Fibromyalgia without tinnitus (n=25) p-value
Age (yr) 54.5±9.3 53.1±8.4 0.828§
Sex 0.629
Male 1 (4.5) 2 (8.0)
Female 21 (95.5) 23 (92.0)
Fibromyalgia duration (mo) 81.7±61.6 85.5±56.3 0.828§
Widespread Pain Index 11.9±5.3 9.2±4.6 0.710
Symptom Severity Score 7.9±2.0 6.6±2.3 0.051§
VAS of pain* 72.5±17.6 64.4±19.2 0.140
Fibromyalgia Impact Questionnaire 66.5±17.8 59.7±18.0 0.199§
Insomnia Severity Index 14.4±6.6 16.2±6.6 0.350§
SF-36
Physical functioning 37.0±17.9 43.0±22.7 0.329§
Role limitation due to physical condition 27.2±35.2 25.0±34.6 0.825
Bodily pain 34.7±19.3 37.6±17.2 0.583
General health 30.0±13.5 34.4±14.0 0.281§
Vitality (energy and fatigue) 27.5±14.1 26.4±15.1 0.799
Social functioning 48.9±22.1 45.0±22.2 0.554§
Role limitation due to emotional condition 44.0±48.7 34.7±43.5 0.494
Mental health 42.7±19.4 38.9±16.2 0.463§
Health change 28.4±28.1 32.0±27.5 0.661
Associated symptoms
Headache 20 (90.9) 21 (84.4) 0.670
Irritable bowel syndrome 5 (22.7) 1 (4.0) 0.085
Used medication 15 (68.2) 19 (76) 0.550

Values are presented as mean±standard deviation or number (%). SF-36: Short-form Health Survey. *The Visual Analog Scale (VAS) of pain intensity is a 100-point linear gauge in which 0=no pain and 100=worst pain imaginable. Satisfies the Rome IV diagnostic criteria. Medication including selective serotonin reuptake inhibitor/serotonin-norepinephrine reuptake inhibitor/ Pregabalin. §t-test; Mann–Whitney U-test; chi-square test.

J Rheum Dis 2021;28:31~37 https://doi.org/10.4078/jrd.2021.28.1.31
© J Rheum Dis